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SUMMARY 
Effect of different monoamines and estradiol were studied on 
cyclic AMP (CAMP) accumulation in hypothalami from 21 day old fe- 
male rats. Incubation for 5 min with 10D4r/r epinephrine, norepine- 
phrine or dopamine resulted in an increase in c!AMP accumulation in 
the hypothals$%s. Incubation of hypothalamic tissue with estra- 
diol (4 x 10 M to 2 x 10 -5M) also resulted in an increase in 
cyclic AMP levels. The increase caused by estradiol was observed 
only after 50 min of incubation period. The estradiol induced 
increase in cyclic AMP accumulation was abolished by both 01 and S 
blockers. These results suggest that the estradiol-induced in- 
crease in cyclic AMP may be mediated by a prior increase in cate- 
cholamines in the hypothalamic tissue. 
Monoaminergic participation in the control of ovulation and 
gonadal function has been suggested (l-3). The level of dopamine 
and norepinephrine in the hypothalamus have been shown to change 
in different physiological conditions associated with altered 
gonadotropin secretion (4). Dopamine has been shown to elevate 
follicle stimulating hormone and luteinizing hormone release both 
in vitro and in vivo by stimulating the release of hypothalamic A- -- 
gonadotropin releasing factors (5-8). Epinephrine was reported 
to be the most effective catecholamine to induce ovulation (9). 
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There is also evidence that pituitary function, significantly 
affected by ovarian hormones, is mediated through adrenergic and 
serotoninergic pathways (4, lo-13), 
These observations prompted an investigation on the effects 
of catecholamines and ovarian steroids on hypothalamic cyclic 
AMP leyels as cyclic AMP has been shown to mediate the action of 
catecholamines in a variety of tissues. 
MATERIALS AND METHODS 
Chemicals: L-Epinephrine, L-Norepinephrine bitartrate, Dopamine 
HCl, Serotonin creatinine sulfate complex and DL-propranolol HCl 
were purchased from Sigma Chemical Co. Phentolamine (Regitine) 
was a product of CIBA. Crystalline estradiol was purchased from 
Steraloids. 
Procedure: 21 day old female rats (Holtzman) were used in this 
study. The rats were sacrificed and the hypothalami were immed- 
iately removed and put in cold Krebs-Ringer Bicarbonate buffer, 
pH 7.4 containing 0.2% glucose (KRBG). Hypothalami were prein- 
cubated in 1.0 ml KRBG for 45 min at 37O C under 95% 02 - 5% Co2 
to deplete the levels of endogenous catecholamines, as suggested 
by Kakiuchi and Rall (14). After 45 min of preincubation, the 
incubation medium was replaced by 1.0 ml fresh KRBG and addi- 
tions were made as indicated under individual experiments. At 
the end of the incubation period, the medium was quickly discarded 
and 1.0 ml of 5% trichloracetic acid was added to each tube con- 
taining the hypothalamic tissue, homogenized and centrifuged at 
7000 rpm for 10 min and cyclic AMP was determined in the super- 
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natant as described by Gilman (15). Results represent the average 
values of minimum three observations in each group. P values are 
calculated using student 't' test. 
RESULTS AND DISCUSSION 
Incubation of rat hypothalamus with 10e4M norepinephrine re- 
sulted in a significant increase (p C 0.05) in CAMP as early as 
2,5 min. The optimum response of about 75% was observed after 
5 min incubation which fell to 57% after 15 min incubation (Fig 
MINUTES 
Fig 1. Time course studies on the effect of norepinephrine on 
rat hypothalamic CAMP level: After preincubation as 
described in the text, hypothalami were incubated in 
1 ml KRBC containing 10m4M norepinephrine in 20 c11 
saline. Control tubes contained 1 ml KRBG with 20 ~1 
saline. 
1) - It was also observed that the incubation of hypothalamus for 
5 min with 10e4M of norepinephrine, epinephrine or dopamine re- 
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sulted in 52% (p L 0.051, 36% (pL 0.025) and 32% (pL 0.025) 
increase in CAMP, respectively, over the control. Serotonin at 
10e4M concentration did not alter the cyclic AMP levels in hypo- 
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Fig 2. Effect of different monoamines on rat hypothalamic &IMP 
level: After preincubation, hypothalami were incubated 
for 5 min with 1 ml KRBG and) 20 ~1 saline containing 
10m4M norepinephrine, epinephrine, dopamine or serotonin. 
Control tubes contained 1 ml KRBG with 20 ul of saline. 
When hypothalamic tissues were separately incubated with 
varying concentrations of estradiol (4 x 10WgM to 4 x 10S3M), an 
increase in CAMP was observed at 4 x 10m7M and optimal stimula- 
tion was observed at 2 x 10m5M. At optimal concentration of 
estradiol (2 x 10M5M), an increase in CAMP accumulation was ob- 
served after 50 min of incubation period and reached maximum at 
70 min after which it declined (Fig 3). 
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Fig 3. Time course studies on the effect of estradiol on rat 
hypothalamic cAMP level: After preincubation, hypothal- 
ami were incubated in 1 ml KRBG with 20 ~1 75% ethanol 
containing 2 x 10'5M estradiol. Control tubes contained 
1 ml KRBG with 20 ~1 75% ethanol. 
Effect of theophylline, an inhibitor of phosphodiesterase, 
on estradiol-induced accumulation in hypothalamic CAMP is shown 
in Fig 4. Theophylline at 10B4M concentration slightly increased 
CAMP accumulation. Theophylline along with estradiol induced an 
additional increase in CAMP in hypothalamus as compared to the 
stimulation of hypothalamic CAMP level caused by estradiol alone 
(Fig 4). 
These results demonstrate that estradiol causes an increase 
in hypothalamic CAMP content. However, estradiol-induced in- 
crease in CAMP is a delayed effect as compared to early increase 
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Fig 4. Effect of estradiol and estradiol plus theophylline on 
the rat hypothalamic CAMP level: After preincubation, 
hypothalami were incubated with 1 ml KRBG with 20 Wl 
75% ethanol containing 4 x 10V6M or 2 x 10'5M estradiol 
alone or along with 20 ~1 of distilled water containing 
10a4M theophylline. Control tubes contained 1 ml KRBG 
and" 20 ~1 75% ethanol. Other groups contained 1 ml 
KRBG with 20 1-11 75% ethanol and 20 I-L1 of 10m4M theo- 
phylline. 
brought about by catecholamines. Many studies have shown that 
the turnover of catecholamines in the hypothalamus as well as in 
the brain is related to the .availability of gonadal steroids (4, 
16-19). Thus it is possible that estradiol-induced CAMP accumula- 
tion may be preceded by an early increase of catecholamines. A 
similar phenomenon has been observed by others on the effect of 
estradiol on uterine CAMP levels (20-21). 
Both c1 and @ adrenergic blockers can overcome the estradiol 
effect on the elevation of hypothalamic CAMP (Fig 5), It is likely 
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Fig 5. Effect of adrenergic blockers on estradiol induced in- 
crease in CAMP level in rat hypothalamus: After prein- 
cubation,hypothalami were incubated with 1 ml IiRBG with 
20 ~1 75% ethanol containing 2 x 10'5M estradiol alone 
or along with 20 ~1 of saline containing 10e7M or 10e5M 
phentolamine or 10B3M propranolol. The following con- 
trols were included: 1) 1 ml KRBG with 20 ~1 75% ethanol 
and 20 ~1 saline, 2) 1 ml KRBG with 20 ~1 75% ethanol 
and 20 ~1 saline containing 10D7M or 10e5M phentolamine 
or 3) 1 ml KRBG in the 20 ~1 75% ethanol and 20 ~1 saline 
containing 10 -3M propranolol. 
that these adrenergic blockers may lack specificity in blocking 
the specific adrenergic receptors in this tissue. It has been 
shown that propranolol which is a B-blocker caused blocade of the 
cl-receptor in the rabbit aortic strips (22). In guinea pig brain, 
cerebellum contains classical B-adrenergic receptors and the rest 
of the brain contains a-adrenergic receptors both of which mediate 
an increase in cAMP accumulation by catecholamines (23). It is 
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also likely that increase in CAMP level brought about by estradiol 
may be through catecholamines influencing a-receptors or the a-re- 
ceptors in turn influencing S-receptors through unknown mechanism(s). 
There are increasing number of studies on the possible role 
of catecholamines as neurotransmitter in the control of the re- 
lease of gonadotropins by promoting the release of gonadotropin 
releasing hormone (Gn-RH). The results of the present study 
suggest a possible role of cAMP in the mediation of gonadal hor- 
mone - catecholamine system on the regulation of GnRH secretion 
at the hypothalamic level. In this context, it is interesting 
to note, that when high doses of dibutyryl CAMP was injected into 
certain regions of the hypothalamus resulted in hyperthermia, 
prolongation of estrous cycle and increased water intake (24, 25), 
further suggesting that cyclic nucleotide may have a regulatory 
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